Daryl Carter, MD: Dr. Carter is a venture advisor at UM Ventures, University of Maryland, and co-founder and Chief Scientific Officer of Otter Immuno-oncology, LLC. With a strong background in clinical medicine and biotech entrepreneurship, Dr. Carter has successfully led companies from inception to clinical trials.  

He is the sole inventor on 14 patents and has managed multiple IND submissions and clinical trials. His work includes groundbreaking research in recurrent pregnancy loss and IVF failures. Dr. Carter also mentors startups, teaches entrepreneurship at UMB, and has contributed to several NIH study sections and business plan competitions.